An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases. In a new study in Science Advances, researchers report that a cocktail of antibodies protected mice—including those with weakened immune systems—from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats.

Unlike current FDA-approved flu treatments, which target viral enzymes and can quickly become useless as the virus mutates, this therapy did not allow viral escape, even after a month of repeated exposure in animals...

Artists are always looking for new ways to create and express themselves. A growing trend is the use of multiple layers of see-through materials, such as Plexiglas, to create paintings that have real depth, transforming two-dimensional images into three-dimensional illusions that feel more realistic and lifelike. But can these layered works be made even more immersive?

A new study, published in Royal Society Open Science, answers this question by demonstrating a novel process to transform a multilayer acrylic painting into a fullcolor, three-dimensional hologram. In addition to offering a striking way to experience art, this technique provides a novel method for preserving and reproducing valuable works.

The researchers used a painting of a tiger titled “Taxonomy Test 1” by reno...

Data and images from NASA’s Mars Perseverance rover reveals that recently discovered rocks in Jezero crater are organic carbon bearing mudstones...

A person will have Alzheimer’s years before ever knowing it. The disorienting erasure of memories, language, thoughts—in essence, all that makes up one’s unique sense of self—is the final act of this enigmatic disease that spends decades disrupting vital processes and dismantling the brain’s delicate structure.

Once symptoms surface and doctors make a diagnosis, though, it can often be too late. Damage is widespread, impossible to reverse. No cure exists.

Attempts to develop drugs that clear away toxic accumulations of amyloid-beta and tau proteins—hallmarks of the disease that cause neurons to die—have ended in hundreds of failed clinical trials. Today, some scientists are skeptical over whether removing amyloid plaques is even enough...